Indclav 1000 Tablet is a combination antibiotic formulation containing Amoxycillin 875 mg and Clavulanic Acid 125 mg, designed to combat a broad spectrum of bacterial infections. Amoxycillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis, leading to cell lysis and death. However, some bacteria produce beta-lactamase enzymes that degrade amoxycillin, rendering it ineffective. Clavulanic Acid acts as a beta-lactamase inhibitor, protecting amoxycillin from enzymatic degradation and thereby extending its antibacterial activity against resistant strains. Indclav 1000 is indicated for the treatment of various infections including respiratory tract infections (such as sinusitis, bronchitis, and pneumonia), urinary tract infections, skin and soft tissue infections, and dental infections caused by susceptible organisms. The combination is effective against both gram-positive and gram-negative bacteria, including beta-lactamase-producing strains. Dosage and duration of therapy should be determined by a healthcare professional based on the severity and type of infection. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Caution is advised in patients with a history of hypersensitivity to penicillins or cephalosporins. Proper adherence to prescribed dosage is essential to prevent antibiotic resistance.